Nello Mainolfi - 01 Jul 2024 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce N. Jacobs, as Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 01 Jul 2024
Net transactions value: +$100,060
Form type: 4
Filing time: 01 Jul 2024, 16:30:10 UTC
Previous filing: 20 Jun 2024
Next filing: 13 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$100,060	+18,773	+3%	$5.33^*	649,959	01 Jul 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-18,773	-6.1%	$0.000000	288,456	01 Jul 2024	Common Stock	18,773	$5.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of May 14, 2020, subject to the reporting person's continued employment through each vesting date.